P. Cravedi

发表

A Prospective, Randomized Study to Compare the Effect of Combination Therapy With Campath-1H on Peripheral Blood Mononuclear Cells in Kidney Transplant Recipients

P. Cravedi, 2009 .

Sirolimus Versus Cyclosporine Therapy Increases Circulating Regulatory T Cells, But Does Not Protect Renal Transplant Patients Given Alemtuzumab Induction From Chronic Allograft Injury

N. Perico, G. Remuzzi, V. D’Agati, 2007, Transplantation.

Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients

E. Zaslavsky, G. Nudelman, P. Cravedi, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Noninvasive methods to assess the risk of kidney transplant rejection

P. Cravedi, R. Mannon, 2009, Expert review of clinical immunology.

Thrice-Weekly In-Center Nocturnal Hemodialysis: An Effective Strategy to Optimize Chronic Dialysis Therapy

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2009, The International journal of artificial organs.

Trends in Immune Cell Function Assay and Donor‐Specific HLA Antibodies in Kidney Transplantation: A 3‐Year Prospective Study

U. Maggiore, M. Luppi, P. Barozzi, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Sirolimus to replace calcineurin inhibitors? Too early yet

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2009, The Lancet.

Immunosuppressive effects of erythropoietin on human alloreactive T cells.

P. Cravedi, A. Mehrotra, J. Brody, 2014, Journal of the American Society of Nephrology : JASN.

Cutting Edge: Receptors for C3a and C5a Modulate Stability of Alloantigen-Reactive Induced Regulatory T Cells

M. Merad, P. Cravedi, E. Paz-Artal, 2013, The Journal of Immunology.

Achieving remission of proteinuria in childhood CKD

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2017, Pediatric Nephrology.

Effect of a Novel Immunosuppressant, ST1959, on the Immune System and Renal Allograft Survival in Rats

G. Remuzzi, P. Cravedi, M. Noris, 2005, Transplantation.

Role of remission clinics in the longitudinal treatment of CKD.

G. Remuzzi, Sanjib K. Sharma, P. Ruggenenti, 2008, Journal of the American Society of Nephrology : JASN.

A large, international study on post-transplant glomerular diseases: the TANGO project

C. Fischman, R. Manfro, G. La Manna, 2018, BMC Nephrology.

Long-Term Outcome of Renal Transplantation from Older Donors

B. Dimitrov, G. Remuzzi, P. Ruggenenti, 2006 .

T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.

C. Fischman, G. La Manna, L. Perin, 2019, Kidney international.

Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury

L. Gesualdo, F. Staffieri, A. Crovace, 2019, Aging.

Acute Renal Failure in Kidney Transplant Recipients

N. Perico, G. Remuzzi, P. Cravedi, 2019, Critical Care Nephrology.

SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts.

J. Wong, J. He, P. Cravedi, 2018, Journal of the American Society of Nephrology : JASN.

Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease

G. Remuzzi, P. Cravedi, 2013, British journal of clinical pharmacology.

Proteinuria should be used as a surrogate in CKD

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2012, Nature Reviews Nephrology.

The role of renin angiotensin system inhibition in kidney repair

G. Remuzzi, I. M. van der Meer, P. Cravedi, 2010, Fibrogenesis & tissue repair.

Pretransplant Donor-specific IFNγ ELISPOT as a Predictor of Graft Rejection: A Diagnostic Test Accuracy Meta-analysis

U. Maggiore, P. Cravedi, O. Bestard, 2019, Transplantation direct.

Rituximab in Membranous Nephropathy: Not All Studies Are Created Equal

P. Cravedi, 2016, Nephron.

Treating the kidney to cure the heart.

G. Remuzzi, P. Cravedi, 2008, Kidney international. Supplement.

Intensified inhibition of renin-angiotensin system: A way to improve renal protection?

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2007, Current hypertension reports.

Does remission of renal disease associated with antihypertensive treatment exist?

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2007, Current hypertension reports.

Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

G. Remuzzi, B. Ene-Iordache, M. Salvadori, 2007, Journal of the American Society of Nephrology : JASN.

Hypertension after kidney transplantation: an important, but still neglected issue.

G. Remuzzi, M. Marasà, P. Cravedi, 2011, Journal of hypertension.

Nondiabetic Kidney Disease

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010 .

Latest treatment strategies for membranous nephropathy

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2007, Expert opinion on pharmacotherapy.

U. Maggiore, E. Fiaccadori, M. Delsante, 2022, Clinical kidney journal.

Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol.

C. Fischman, L. Rostaing, P. Cravedi, 2019, Transplant immunology.

Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation

U. Maggiore, L. Perin, P. Cravedi, 2018, PloS one.

Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial

G. Remuzzi, F. Gaspari, M. Marasà, 2021, PLoS medicine.

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

M. Rudnicki, G. Capasso, R. Pollastro, 2014, Journal of the American Society of Nephrology : JASN.

Old Donors for Kidney Transplantation: How Old?

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010, Gerontology.

Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature

G. La Manna, P. Cravedi, A. Angeletti, 2017, Journal of clinical case reports.

Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

R. Colvin, U. Maggiore, W. Baldwin, 2017, Journal of the American Society of Nephrology : JASN.

Preimplantation Histological Score Associates with 6-Month GFR in Recipients of Perfused, Older Kidney Grafts: Results from a Pilot Study

G. Remuzzi, P. Ruggenenti, A. Perna, 2021, Nephron.

Making Procurement Biopsies Important Again for Kidney Transplant Allocation

P. Cravedi, A. Angeletti, 2019, Nephron.

Dual Kidney Transplantation

P. Ruggenenti, P. Cravedi, A. Angeletti, 2017 .

Acute Cellular Rejection

P. Cravedi, F. Salem, M. Menon, 2017 .

Immune Cell‐Derived C3a and C5a Costimulate Human T Cell Alloimmunity

P. Cravedi, P. Heeger, M. Donovan, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium

U. Maggiore, P. Cravedi, G. Zaza, 2020, American Journal of Transplantation.

A STEP TOWARDS CLINICAL APPLICATION OF ACELLULAR MATRIX: A CLUE FROM MACROPHAGE POLARIZATION: MP23‐02

Stefano Da Sacco, R. D. De Filippo, L. Perin, 2017, Matrix biology : journal of the International Society for Matrix Biology.

A Multidrug, Antiproteinuric Approach to Alport Syndrome: A Ten-Year Cohort Study

G. Remuzzi, F. Gaspari, D. Roccatello, 2015, Nephron.

Effects of Antirejection Drugs on Innate Immune Cells After Kidney Transplantation

G. Gambaro, P. Cravedi, G. Zaza, 2019, Front. Immunol..

Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus

E. Fiaccadori, G. La Manna, P. Cravedi, 2019, Front. Immunol..

Acute Kidney Injury (AKI) before and after Kidney Transplantation: Causes, Medical Approach, and Implications for the Long-Term Outcomes

U. Maggiore, E. Fiaccadori, M. Delsante, 2021, Journal of clinical medicine.

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone

P. Cravedi, A. Angeletti, J. Leventhal, 2020, American Journal of Kidney Diseases.

Preventing Coronavirus Disease 2019 in Kidney Transplant Recipients: Where Should We Begin?

J. Azzi, P. Cravedi, L. Riella, 2021, Nephron.

Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data

P. Cravedi, J. Leventhal, Samuel Mon-Wei Yu, 2020, Journal of Nephrology.

Monitoring alloimmune response in kidney transplantation

P. Cravedi, O. Bestard, 2017, Journal of Nephrology.

Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity.

Christopher D. Scharer, M. Cragg, P. Cravedi, 2020, Immunity.

Comment on: Robertson (2010) Islet Transplantation a Decade Later and Strategies for Filling a Half-Full Glass. Diabetes;59:1285–1291

G. Remuzzi, A. Remuzzi, P. Cravedi, 2010, Diabetes.

Regulatory T cells under scrutiny

P. Cravedi, S. Aiello, 2004 .

Induced Regulatory T Cells Modulate Stability of Alloantigen-Reactive Cutting Edge: Receptors for C3a and C5a

M. Merad, P. Cravedi, E. Paz-Artal, 2013 .

Monitoring T cell alloreactivity.

P. Cravedi, A. Mehrotra, J. Leventhal, 2015, Transplantation reviews.

Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone

P. Cravedi, Chiara Cantarelli, Meghana Eswarappa, 2021, Frontiers in Immunology.

Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra

G. Ghiggeri, G. Caridi, F. Lugani, 2021 .

Refractory minimal change disease and FSGS treated with Anakinra

G. Ghiggeri, G. Caridi, F. Lugani, 2021, Kidney International Reports.

New biologics in the treatment of rare glomerular diseases of childhood

G. Remuzzi, P. Cravedi, A. Angeletti, 2017, Current opinion in pharmacology.

β-cell transplantation for diabetes therapy – Authors' reply

G. Remuzzi, A. Remuzzi, P. Ruggenenti, 2008, The Lancet.

The spatially resolved transcriptional profile of acute T-cell mediated rejection in a kidney allograft.

G. Ghiggeri, S. Sedrakyan, L. Perin, 2021, Kidney international.

Natural Antibody and Complement Activation Characterize Patients with Idiopathic Nephrotic Syndrome.

B. Rovin, J. Thurman, V. M. Holers, 2021, American journal of physiology. Renal physiology.

Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study

U. Maggiore, L. Peruzzi, G. Regolisti, 2021, PloS one.

Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy.

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity

Zeguo Sun, Zhongyang Zhang, S. Kulkarni, 2022, Journal of the American Society of Nephrology : JASN.

Immune and gene expression profiling during tacrolimus to everolimus conversion early after liver transplantation.

P. Cravedi, S. Kurian, J. Mathew, 2020, Human immunology.

The marginal kidney donor

U. Maggiore, P. Cravedi, 2014, Current opinion in organ transplantation.

Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation

U. Maggiore, E. Fiaccadori, P. Cravedi, 2022, Clinical kidney journal.

Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanisms

A. Sharpe, J. Azzi, X. Li, 2021, JCI insight.

Immune responses to SARS-CoV-2 in dialysis and kidney transplantation

L. Perin, P. Cravedi, M. A. Podestà, 2022, Clinical kidney journal.

Effect of disease progression on the podocyte cell cycle in Alport Syndrome.

K. Lemley, V. Villani, R. D. De Filippo, 2021, Kidney international.

Optimizing Allocation of Kidneys from Older Donors

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010, Pharmaceuticals.

Alterations of Type IV Collagen α Chains in Patients with Chronic Acquired Glomerulopathies: mRNA Levels, Protein Expression and Urinary Loss

U. Maggiore, S. Sanna-Cherchi, L. Allegri, 2007, American Journal of Nephrology.

A catabolic state in a kidney transplant recipient with COVID‐19

P. Cravedi, S. Farouk, V. Delaney, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Regulatory T cells and T cell depletion: role of immunosuppressive drugs.

N. Perico, G. Remuzzi, F. Gaspari, 2007, Journal of the American Society of Nephrology : JASN.

Glomerular endothelial cell heterogeneity in Alport syndrome

V. Villani, S. Sedrakyan, R. D. De Filippo, 2020, Scientific Reports.

Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.

G. Remuzzi, I. Codreanu, P. Ruggenenti, 2006, Clinical journal of the American Society of Nephrology : CJASN.

CHAPTER 28 – Thrombotic Microangiopathies, Including Hemolytic Uremic Syndrome

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010 .

Kidney Failure Associates With T Cell Exhaustion and Imbalanced Follicular Helper T Cells

P. Cravedi, L. Gallon, Weijia Zhang, 2020, Frontiers in Immunology.

T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival

T. Woodruff, S. Lira, P. Cravedi, 2018, The Journal of Immunology.

Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases.

P. Cravedi, J. Manrique, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study

G. Remuzzi, M. Marasà, P. Ruggenenti, 2011, American Journal of Nephrology.

Low‐Dose Rituximab for Posttransplant Recurrent Membranous Nephropathy

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Proinflammatory Activation of Renal Tubular Cells by Normal and Pathologic IgG

L. Allegri, N. Ronda, P. Lunghi, 2005, Nephron Experimental Nephrology.

35-1 Microvascular and Macrovascular Diseases of the Kidney

P. Ruggenenti, P. Cravedi, 2015 .

Sirolimus for calcineurin inhibitors in organ transplantation: contra.

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010, Kidney international.

Islet transplantation: need for a time-out?

G. Remuzzi, A. Remuzzi, P. Ruggenenti, 2008, Nature Clinical Practice Nephrology.

Eosinophils Are Not Required for the Induction and Maintenance of an Alloantibody Response

P. Cravedi, P. Heeger, D. Lessman, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Pro-Tolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.

N. Perico, G. Remuzzi, C. Rota, 2019, Transplantation.

Immunosuppressive Effects of the Traditional Chinese Herb Qu Mai on Human Alloreactive T Cells

P. Cravedi, Y. Song, P. Heeger, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Predicting Cisplatin-Induced Acute Kidney Injury by Urinary Neutrophil Gelatinase-Associated Lipocalin Excretion: A Pilot Prospective Case-Control Study

R. Labianca, N. Perico, G. Remuzzi, 2010, Nephron Clinical Practice.

Erythropoietin Reduces Auto- and Alloantibodies by Inhibiting T Follicular Helper Cell Differentiation

E. Fiaccadori, G. La Manna, P. Cravedi, 2021, Journal of the American Society of Nephrology : JASN.

Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial

G. Remuzzi, B. Ene-Iordache, F. Gaspari, 2011, Journal of hypertension.

The impact of dupilumab treatment on SARS‐CoV‐2 T cell responses in atopic dermatitis patients

P. Cravedi, A. Golant, G. Singer, 2022, Allergy.

Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab

M. Marasà, P. Ruggenenti, P. Cravedi, 2014, BMJ Case Reports.

Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity

P. Cravedi, A. Angeletti, Chiara Cantarelli, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation

G. Remuzzi, M. Marasà, P. Ruggenenti, 2012, Journal of transplantation.

Cyclosporine Prolongs Delayed Graft Function in Kidney Transplantation: Are Rabbit Anti-Human Thymocyte Globulins the Answer?

G. Remuzzi, I. Codreanu, P. Ruggenenti, 2005, Nephron Clinical Practice.

Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

G. Remuzzi, F. Gaspari, P. Ruggenenti, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Mycophenolate Mofetil Versus Azathioprine in Organ Transplantation

G. Remuzzi, P. Ruggenenti, A. Perna, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Proteinuria: Increased angiotensin-receptor blocking is not the first option

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2009, Nature Reviews Nephrology.

Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients

U. Maggiore, P. Cravedi, G. Zaza, 2022, Frontiers in Immunology.

Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2011, Journal of the American Society of Nephrology : JASN.

Novel therapies for membranous nephropathy: focus on rituximab

P. Cravedi, 2009 .

Rituximab for membranous nephropathy and immune disease: less might be enough

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2009, Nature Clinical Practice Nephrology.

Lymphocyte depletion for kidney transplantation: back to the past?

G. Remuzzi, P. Cravedi, R. Mannon, 2008, Nature Clinical Practice Nephrology.

Membranous nephropathy: setting the bar for hypothesis-driven, selective therapies in nephrology

P. Cravedi, A. Angeletti, J. Leventhal, 2020, Journal of Nephrology.

Prolonged Intradialytic Hypoxemia Is Associated With Functional Disturbances in Erythrocytes

P. Cravedi, S. Hartzell, S. Farouk, 2021, Kidney international reports.

Vaccines and Disease Relapses in Children with Nephrotic Syndrome.

G. Ghiggeri, F. Lugani, P. Cravedi, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Ofatumumab or Rituximab for Children with Steroid- and Calcineurin Inhibitor -Dependent Nephrotic Syndrome - A Superiority Randomized Controlled Trial (OFA2)

M. Prunotto, P. Ravani, G. Ghiggeri, 2021 .

Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial

M. Prunotto, P. Ravani, G. Ghiggeri, 2021, Journal of the American Society of Nephrology : JASN.

Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis

P. Cravedi, J. Levitsky, C. Mack, 2022, Hepatology.

Microvascular and Macrovascular Diseases of the Kidney

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2011 .

Complement in Non-Antibody-Mediated Kidney Diseases

P. Cravedi, K. Campbell, A. Angeletti, 2017, Front. Med..

Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence

G. Remuzzi, P. Cravedi, J. Kopp, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rethinking Regenerative Medicine From a Transplant Perspective (and Vice Versa)

B. Bussolati, P. Cravedi, G. Migliaccio, 2019, Transplantation.

Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response

L. L. Cunha, J. Azzi, P. Cravedi, 2020, Frontiers in Immunology.

COVID-19 and the Kidneys: An Update

P. Cravedi, G. Zaza, L. Riella, 2020, Frontiers in Medicine.

T Cells and Acute Kidney Injury: A Two-Way Relationship

P. Cravedi, S. Dellepiane, J. Leventhal, 2020, Frontiers in Immunology.

The COVID‐19 pandemic: A community approach

J. Schold, J. Azzi, P. Cravedi, 2020, Clinical transplantation.

Review: Ischemia Reperfusion Injury—A Translational Perspective in Organ Transplantation

P. Cravedi, J. Ochando, M. López-Hoyos, 2020, International journal of molecular sciences.

The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes

U. Maggiore, A. Vaglio, G. La Manna, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.

Zeguo Sun, R. Colvin, E. Lerut, 2019, Journal of the American Society of Nephrology : JASN.

The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas

Panagiotis Maghsoudlou, Paolo De Coppi, Ravi Katari, 2016, Annals of surgery.

Rituximab in idiopathic membranous nephropathy.

G. Remuzzi, F. Gaspari, M. Marasà, 2012, Journal of the American Society of Nephrology : JASN.

A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier

V. Villani, Stefano Da Sacco, R. D. De Filippo, 2019, Nature Communications.

Linking erythropoietin to Treg-dependent allograft survival through myeloid cells

J. Madsen, P. Cravedi, R. Fairchild, 2022, JCI insight.

Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.

V. D’Agati, U. Maggiore, E. Fiaccadori, 2019, JCI insight.

Erythropoietin inhibits SGK 1-dependent Th 17 cell induction and Th 17 cell – dependent kidney disease

V. D’Agati, U. Maggiore, E. Fiaccadori, 2019 .

T-cell Exhaustion in Organ Transplantation

P. Cravedi, L. Riella, M. Fribourg, 2021, Transplantation.

Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial

G. Remuzzi, B. Ene-Iordache, P. Ruggenenti, 2010, Journal of ophthalmology.

Complement and Complement Targeting Therapies in Glomerular Diseases

P. Cravedi, G. Zaza, J. Leventhal, 2019, International journal of molecular sciences.

Complement as a multifaceted modulator of kidney transplant injury.

P. Cravedi, P. Heeger, 2014, The Journal of clinical investigation.

Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

M. Stegall, B. Rovin, M. Sarwal, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Immune-Monitoring Disease Activity in Primary Membranous Nephropathy

P. Cravedi, O. Bestard, Marta Jarque, 2019, Front. Med..

DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.

K. Zen, V. D’Agati, Zhihong Liu, 2021, The Journal of clinical investigation.

Targeting the Renin Angiotensin System in Dialysis Patients

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2011, Seminars in dialysis.

Immunologic monitoring in transplantation revisited

P. Cravedi, P. Heeger, 2012, Current opinion in organ transplantation.

The RAAS in the pathogenesis and treatment of diabetic nephropathy

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010, Nature Reviews Nephrology.

Blood transcriptomes of SARS-CoV-2 infected kidney transplant recipients demonstrate immune insufficiency

P. Cravedi, G. Tietjen, E. Akalin, 2022, medRxiv.

Interleukin-1β-induced IRAK1 ubiquitination is required for TH-GM-CSF cell differentiation in T cell-mediated inflammation.

M. Merad, Chen-feng Qi, Liwu Li, 2019, Journal of autoimmunity.

Recurrence of FSGS after Kidney Transplantation in Adults.

G. M. Neto, R. Manfro, G. La Manna, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?

U. Maggiore, E. Fiaccadori, S. Buti, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Prognostic significance of albuminuria in patients with renal cell cancer.

A. Vaglio, P. Cravedi, C. Buzio, 2003, The Journal of urology.

Membranous nephropathy associated with IgG4-related disease.

G. Remuzzi, V. D’Agati, D. Salant, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Editorial: Mechanistic and therapeutic advances in antibody-mediated rejection: reasons to be optimistic.

P. Cravedi, M. A. Podestà, 2022, Current opinion in organ transplantation.

Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis.

U. Maggiore, P. Cravedi, R. Mannon, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Immune responses towards bioengineered tissues and strategies to control them.

P. Cravedi, A. Angeletti, Chiara Cantarelli, 2019, Current opinion in organ transplantation.

Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.

G. Nadkarni, J. He, P. Cravedi, 2017, Kidney International.

Complement regulation of T-cell alloimmunity.

P. Cravedi, P. Heeger, W. van der Touw, 2013, Seminars in nephrology.

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options

P. Cravedi, E. Morales, J. Manrique, 2021, Frontiers in Medicine.

COVID-19 and the Kidney: A Worrisome Scenario of Acute and Chronic Consequences

P. Cravedi, J. Hindi, J. Chancay, 2021, Journal of clinical medicine.

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

P. Cravedi, A. Angeletti, Chiara Cantarelli, 2019, Front. Med..

Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection

C. Fischman, Stefano Da Sacco, L. Perin, 2019, Transplantation direct.

Immunological Impact of a Gluten-Free Dairy-Free Diet in Children With Kidney Disease: A Feasibility Study

T. Libermann, J. Bonventre, F. Hildebrandt, 2021, Frontiers in Immunology.

COVID-19 and the kidney: what we think we know so far and what we don’t

E. Fiaccadori, P. Cravedi, S. Farouk, 2020, Journal of Nephrology.

COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression.

G. Ghiggeri, G. Caridi, P. Cravedi, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates

P. Cravedi, J. Maltzman, E. Akalin, 2022, Transplantation.

A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti–Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients

Uri Laserson, U. Maggiore, E. Fiaccadori, 2020, Kidney international reports.

Rituximab for idiopathic membranous nephropathy: who can benefit?

G. Remuzzi, P. Ruggenenti, A. Perna, 2006, Clinical journal of the American Society of Nephrology : CJASN.

COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry

U. Maggiore, E. Fiaccadori, M. Delsante, 2021, Kidney360.

Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring

E. Fiaccadori, M. Delsante, G. La Manna, 2020, Kidney International.

Handling immune-suppressive therapies during SARS-CoV-2 pandemic: insights from pediatric datasets

G. Ghiggeri, P. Cravedi, A. Angeletti, 2020, Journal of Nephrology.

Mortality in solid organ transplant recipients with COVID-19: More than meets the eye

U. Maggiore, J. Azzi, P. Cravedi, 2021, American Journal of Transplantation.

Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection

P. Cravedi, J. Maltzman, E. Akalin, 2021, Journal of the American Society of Nephrology : JASN.

Anti‐HLA and anti‐SARS‐CoV‐2 antibodies in kidney transplant recipients with COVID‐19

U. Maggiore, E. Fiaccadori, P. Cravedi, 2021, Transplant International.

Complement, a Therapeutic Target in Diabetic Kidney Disease

P. Cravedi, S. Dellepiane, Samuel Mon-Wei Yu, 2021, Frontiers in Medicine.

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine

P. Cravedi, F. Salem, Miriam Chung, 2021, Kidney International Reports.

Risk of COVID‐19 in young kidney transplant recipients. Results from a single‐center observational study

G. Ghiggeri, P. Cravedi, A. Magnasco, 2020, Clinical transplantation.

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2014, Nephron Clinical Practice.

Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.

Zeguo Sun, N. Rogers, P. Cravedi, 2021, Kidney international.

COVID-19 in kidney transplant recipients

U. Maggiore, L. Peruzzi, E. Fiaccadori, 2020, American Journal of Transplantation.

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome

P. Ravani, G. Ghiggeri, G. Caridi, 2022, Kidney international reports.

Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients

P. Cravedi, Adeeb H. Rahman, G. Zaza, 2020, American Journal of Transplantation.

Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination

V. Pattanayak, J. Azzi, P. Cravedi, 2022, Frontiers in Immunology.

Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis

V. D’Agati, E. Fiaccadori, C. Fischman, 2020, The Journal of experimental medicine.

Regenerative immunology: the immunological reaction to biomaterials

L. Perin, P. Cravedi, G. Orlando, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Which antihypertensive drugs are the most nephroprotective and why?

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2010, Expert opinion on pharmacotherapy.

Mechanisms and treatment of CKD.

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2012, Journal of the American Society of Nephrology : JASN.

Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.

G. Remuzzi, M. Tonelli, B. Ene-Iordache, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Current Status of Islet Transplantation

G. Remuzzi, A. Remuzzi, P. Ruggenenti, 2014 .

Successes and disappointments with clinical islet transplantation.

G. Remuzzi, I. M. van der Meer, P. Ruggenenti, 2010, Advances in experimental medicine and biology.

Criteria for Living Donation from Marginal Donors: One, No One, and One Hundred Thousand

P. Cravedi, Chiara Cantarelli, 2019, Nephron.

Rethinking clinical endpoints in kidney transplant trials.

U. Maggiore, P. Cravedi, J. Leventhal, 2019, Current opinion in organ transplantation.

Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation

D. Hesselink, R. Manfro, P. Cravedi, 2022, Kidney international reports.

Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution

P. Khoueiry, J. Azzi, R. Abdi, 2023, Frontiers in Immunology.

CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome

G. Ghiggeri, L. Perin, P. Cravedi, 2021, Frontiers in Immunology.

Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives.

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2011, Current diabetes reviews.

Non-immune interventions to protect kidney allografts in the long term.

N. Perico, G. Remuzzi, P. Cravedi, 2010, Kidney international. Supplement.

Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA

N. Perico, G. Remuzzi, B. Ene-Iordache, 2012, BMJ Open.

Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Zeguo Sun, R. Colvin, S. Alexander, 2019, JCI insight.

Repository Corticotropin Injections Promote Clinical Remission and Regulatory T Cell Expansion in Membranous Nephropathy

P. Cravedi, M. Fribourg, S. Hartzell, 2021, Kidney international reports.

Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.

T. Schiano, P. Cravedi, M. Fribourg, 2021, Journal of autoimmunity.

Interferon-β acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation.

S. Sealfon, P. Cravedi, P. Heeger, 2022, Immunity.

Recurrence of IgA Nephropathy after Kidney Transplantation in Adults

J. Schold, J. Pascual, R. Manfro, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Deep learning identifies pathological abnormalities predictive of graft loss in kidney transplant biopsies

Zeguo Sun, R. Colvin, N. Rogers, 2021, bioRxiv.

THE HUMAN PANCREAS AS A SOURCE OF PRO-TOLEROGENIC EXTRACELLULAR MATRIX SCAFFOLD FOR A NEW GENERATION BIO-ARTIFICIAL ENDOCRINE PANCREAS Running title : Human-derived pancreatic scaffolds

John P McQuilling, S. Soker, R. Stratta, 2017 .

The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy

P. Cravedi, A. Rajasekaran, J. Faith, 2022, Kidney360.

Prevention of progression and remission/regression strategies for chronic renal disease

P. Ruggenenti, P. Cravedi, 2009 .

Report of the first World Transplant Congress.

G. Remuzzi, P. Cravedi, M. Noris, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?

P. Cravedi, J. Leventhal, Chiara Cantarelli, 2021, Kidney international reports.

Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation.

U. Maggiore, E. Fiaccadori, P. Cravedi, 2023, Kidney International.

Decay-Accelerating Factor Expression Modulates the Severity of Experimental Focal Segmental Glomerulosclerosis

G. La Manna, J. Azzi, P. Cravedi, 2022, Kidney360.

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease

G. Stallone, P. Cravedi, G. Zaza, 2023, Kidney international reports.

Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation

J. Friedewald, M. Abecassis, U. Maggiore, 2017, Kidney international reports.

Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.

N. Lloberas, J. Grinyó, P. Cravedi, 2017, Kidney international.

Post-transplant peripheral blood donor-specific IFN-γ ELISPOT assays differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

J. Grinyó, P. Cravedi, J. Martorell., 2018 .

Glomerular endothelial cell heterogeneity in Alport syndrome

V. Villani, S. Sedrakyan, R. D. De Filippo, 2020, Scientific Reports.

Deep-learning Based Pathological Assessment of Frozen Procurement Kidney Biopsies Predicts Graft Loss and Guides Organ Utilization: A Large-scale Retrospective Study

Zeguo Sun, P. Cravedi, Chengguo Wei, 2023, bioRxiv.

Decay-Accelerating Factor Restrains Complement Activation and Delays Progression of Murine cBSA-Induced Membranous Nephropathy

E. Fiaccadori, L. Perin, P. Cravedi, 2023, Kidney360.

Identification and Characterization of the Wilms Tumor Cancer Stem Cell.

M. Csete, K. Lemley, V. Villani, 2023, Advanced science.

Immune abnormalities in IgA nephropathy

E. Fiaccadori, P. Cravedi, F. Pesce, 2023, Clinical kidney journal.

Control of tertiary lymphoid tissue revealed

P. Cravedi, Xian C. Li, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis

F. Scolari, G. Ghiggeri, L. Allegri, 2019, The Journal of Rheumatology.

Looking into the Graft without a Biopsy: Biomarkers of Acute Rejection in Renal Transplantation.

P. Cravedi, A. Angeletti, 2017, Contributions to nephrology.

Type I interferons augment regulatory T cell polarization in concert with ancillary cytokine signals

J. Azzi, I. Ghobrial, P. Cravedi, 2023, Frontiers in Transplantation.

Liquid biopsy for non-invasive monitoring of patients with kidney transplants

J. Azzi, P. Cravedi, Connor A. O'Brien, 2023, Frontiers in Transplantation.

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients

P. Cravedi, M. Ansari, J. Leventhal, 2022, Frontiers in Immunology.

A Prospective, Randomized Study to Compare the Effect of Combination Therapy With Campath-1H on Peripheral Blood Mononuclear Cells in Kidney Transplant Recipients

P. Cravedi, 2009 .

ReviewThe role of renin angiotensin system inhibition in kidney repair

G. Remuzzi, I. M. van der Meer, P. Cravedi, 2015 .

Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation

P. Cravedi, S. Kim-Schulze, M. Fribourg, 2023, bioRxiv.

Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

R. Colvin, U. Maggiore, W. Baldwin, 2017, Journal of the American Society of Nephrology : JASN.

Immune Cell‐Derived C3a and C5a Costimulate Human T Cell Alloimmunity

P. Cravedi, P. Heeger, M. Donovan, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anti-PLA2R1 antibodies in membranous nephropathy: do we have the smoking gun?

P. Cravedi, M. Fribourg, 2023, Kidney International.

Mechanisms and treatment of CKD.

G. Remuzzi, P. Ruggenenti, P. Cravedi, 2012, Journal of the American Society of Nephrology : JASN.

The role of renin angiotensin system inhibition in kidney repair

G. Remuzzi, I. M. van der Meer, P. Cravedi, 2010, Fibrogenesis & tissue repair.

Long-term outcome of renal transplantation from older donors.

B. Dimitrov, G. Remuzzi, P. Ruggenenti, 2006, The New England journal of medicine.

COVID-19 Infection in Patients with Glomerular Disease: Follow-up Results from the IRoc-GN International Registry

U. Maggiore, E. Fiaccadori, M. Delsante, 2021 .

Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.

V. D’Agati, U. Maggiore, E. Fiaccadori, 2019, JCI insight.

Editorial: New perspectives to increase transplant numbers and survival.

P. Cravedi, 2019, Current opinion in organ transplantation.

New perspectives to increase transplant numbers and survival

P. Cravedi, 2018, Current Opinion in Organ Transplantation.

Complement as a multifaceted modulator of kidney transplant injury.

P. Cravedi, P. Heeger, 2014, The Journal of clinical investigation.

The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas

John P McQuilling, S. Soker, R. Stratta, 2016, Annals of surgery.

Eosinophils Are Not Required for the Induction and Maintenance of an Alloantibody Response

P. Cravedi, Peter S. Heeger, D. A. Lessman, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

D. Dadhania, M. Montez-Rath, P. Cravedi, 2023, Transplant Infectious Disease.

Kidney immunology: embracing the complexity to advance the field

P. Cravedi, L. Riella, 2021, Clinical kidney journal.

The Impact of Histologic Variants on FSGS Outcomes

P. Cravedi, K. Campbell, M. Schwartzman, 2014, International scholarly research notices.

ACTH action on podocytes: mystery solved?

P. Cravedi, K. Campbell, 2016, American journal of physiology. Renal physiology.

ACTH action on podocytes : mystery solved ? 11 12 13

P. Cravedi, K. Campbell, 2016 .

The role of renin angiotensin system inhibition in kidney repair

G. Remuzzi, P. Cravedi, Irene M van der Meer, 2010, Fibrogenesis & tissue repair.

Role of remission clinics in the longitudinal treatment of CKD.

G. Remuzzi, P. Ruggenenti, A. Perna, 2008, Journal of the American Society of Nephrology : JASN.

A Multidrug, Antiproteinuric Approach to Alport Syndrome: A Ten-Year Cohort Study

G. Remuzzi, F. Gaspari, D. Roccatello, 2015, Nephron.

Endogenous erythropoietin has immunoregulatory functions that limit the expression of autoimmune kidney disease in mice

G. La Manna, P. Cravedi, P. Heeger, 2023, Frontiers in immunology.

CD55 Deficiency and Protein-Losing Enteropathy.

M. Marasà, P. Cravedi, A. Angeletti, 2017, New England Journal of Medicine.

Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation

C. Aspord, P. Cravedi, Johan Noble, 2024, Transplant international : official journal of the European Society for Organ Transplantation.

Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases

G. Ghiggeri, G. Caridi, P. Cravedi, 2024, Kidney international reports.

Recurrence of membranous nephropathy after kidney transplantation: a multicenter retrospective cohort study.

R. Manfro, P. Cravedi, E. Akalin, 2024, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A STEP TOWARDS CLINICAL APPLICATION OF ACELLULAR MATRIX: A CLUE FROM MACROPHAGE POLARIZATION: MP23‐02

R. D. De Filippo, L. Perin, P. Cravedi, 2017, Matrix biology : journal of the International Society for Matrix Biology.

Genetic polymorphisms of Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3) gene in African American kidney transplant recipients are associated with post-transplant graft failure

Daniel R. Schrider, Zeguo Sun, P. Cravedi, 2024, bioRxiv.

What makes the kidney so tolerant?

P. Cravedi, Paolo Molinari, 2024, The Journal of clinical investigation.

Hypertension and glomerular diseases: the importance of a holistic approach

P. Cravedi, G. Piccoli, Jeremy S. Leventhal, 2021, Journal of Nephrology.

Increased Complement Gene Expression in Circulating B Cells From Kidney Transplant Recipients With Chronic Antibody-Mediated Rejection

P. Pontrelli, G. Grandaliano, P. Cravedi, 2022, Kidney international reports.

High-dimensional Mass Cytometry identified circulating Natural Killer T-cell subsets associated with protection from Cytomegalovirus infection in kidney transplant recipients.

P. Cravedi, A. Loupy, S. Hartzell, 2024, Kidney international.

Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation.

P. Cravedi, Frank Hullekes, Shota Obata, 2024, Transplantation reviews.

Recurrent C3 glomerulopathy after kidney transplantation.

P. Cravedi, L. Riella, Shota Obata, 2024, Transplantation reviews.

Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis

U. Maggiore, J. Azzi, P. Cravedi, 2020, Kidney international reports.